Vision_INM

The new year has just begun and we already have novel RNU breakthroughs to share, this time in the eye genetics field: De novo and inherited dominant variants in U4 and U6 snRNAs cause retinitis pigmentosa medrxiv.org/content/10.110…

I am proud to announce that we made the cover of the December issue of Molecular Therapy with an image of CRALBP expression in a human #retinal #organoid accompanying our published paper on #RLBP1. Congratulations H. Boukhaddaoiu for imaging and N. Erkilic for differentiation.

I am thrilled to announce that our latest article concerning #RLBP1, associated #IRD models, and #AAV-mediated gene replacement therapy is available online in Molecular Therapy. A big thank you to everyone involved. kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F%2…

Just finished a fantastic @iserworld meeting here in Buenos Aires, Argentina. Presented our work on #USH2A- and #RLBP1-associated IRDs. Heard a lot of exciting science. Congratulations to the organisers.

Nous recrutons un(e) IE pour travailler sur l’édition génomique des iPSC. Pour plus de détails et afin de candidater, consulter : umontpellier.nous-recrutons.fr/poste/q0npkp4p…

Absolutely thrilled that our article on #USH2A retinal #organoids published in @HGGAdvances was hand-picked by the editors of @CellPressNews

@CellPressNews @HGGAdvances @INM_Montpellier @GeneticsSociety Absolutely thrilled that our paper on #USH2A retinal #organoids published in @HGGAdvances was hand-picked by the editors of @CellPressNews

USH2A variants causing retinitis pigmentosa or Usher syndrome provoke differential retinal phenotypes in disease-specific organoids hubs.li/Q02vx0Cr0 @HGGAdvances paper hand-picked by our editors @Vision_INM @INM_Montpellier @GeneticsSociety

An enormous thank you to France Choroideremie and @curechm for their indispensable sponsorship. Happy 20th birthday France Choroideremie!

We also thank the patient association representatives of France choroideremie @curechm @ProRetinaDe @fightforsightUK for their presence and contribution to the success of the meeting.

A big thank you to all the scientists that came to Montpellier to participate in our 4th International Choroideremia Symposium. A day of stimulating scientific presentations and discussions concerning #choroideremia.

Very much impressed by the professionalism, enthusiasm, knowledge and warm interactions of @curechm Big thank you Viki @Vision_INM and @INM_Montpellier colleagiues for the invitation, congrats on this top scientific and patient meeting 👌

We are happy to report that our latest article concerning #RLBP1, #IRDs and #gene therapy is available on BioRxiv. A collaboration with the @unil and @NIH.

Dual CRALBP isoforms unveiled: iPSC-derived retinal modelling and AAV2/5-RLBP1 gene transfer raise considerations for effective therapy biorxiv.org/cgi/content/sh… #biorxiv_molbio

Correction to contact address: france.choroideremie@gmail.com

We are hosting the 4th International #Choroideremia Research Symposium on 17th May and CHM patient information day on 18th May 2024. All patients welcome to attend. Please contact france.choroideremia@gmail.com for further information. @choroideremia @CureCHM #IRDs #Retina

Reminder for prospective PhD candidates, applications for our Marie Skłodowska-Curie Doctoral Network (2024-2027) named ProgRET closes Friday 15th March. All information on the program and application process can be found here: progret.eu/apply.html @Euroaxess #IRD #Retina

@Vision_INM supports #RareDiseaseDay Working daily for and alongside patients affected with rare inherited retinal disorders

More info on: progret.eu @Euraxess @UGent @radboudumc @uni_tue @Tigem_Telethon @INM_Montpellier @CABD_UPO_CSIC @CharlesUniPRG @Evotec @elfridedebaere @CoppietersF @collinrwj @SusanneRoosing @PietroDeAngeli9 @BanfisLab @Vision_INM @jjtenagu @JuanRMartinezMo